Chairman emeritus Peter C. Farrell - 23 Jun 2022 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Director
Signature
/s/ Ilan Katz, attorney-in-fact
Issuer symbol
ARCT
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
27 Jun 2022, 19:16:49 UTC
Previous filing
26 Jan 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Stock Option (right to buy) Award $0 +15,000 $0.000000 15,000 23 Jun 2022 Common Stock 15,000 $16.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the option vest monthly over a one year period from the date of grant. This grant represents the annual grant to members of the Board of Directors.